Rationale and Design of the National Emphysema Treatment Trial
Author:
- Group The National Emphysema Treatment Trial ResearchGRGroup The National Emphysema Treatment Trial Research
Open Access
- 1 December 1999
- Vol. 116 (6) , 1750-1761
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Survival and FEV1 Decline in Individuals with Severe Deficiency of α1-AntitrypsinAmerican Journal of Respiratory and Critical Care Medicine, 1998
- Pulmonary RehabilitationChest, 1997
- Quality of Life Changes in COPD Patients Treated With SalmeterolAmerican Journal of Respiratory and Critical Care Medicine, 1997
- Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary diseaseThe Lancet, 1996
- Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task ForceEuropean Respiratory Journal, 1995
- Antibiotics in Chronic Obstructive Pulmonary Disease ExacerbationsJAMA, 1995
- Effects of Smoking Intervention and the Use of an Inhaled Anticholinergic Bronchodilator on the Rate of Decline of FEV1JAMA, 1994
- The National Mucolytic StudyChest, 1990
- Guidelines For The Approach To The Patient With Severe Hereditary Alpha-1-Antitrypsin DeficiencyAmerican Review of Respiratory Disease, 1989
- Continuous or Nocturnal Oxygen Therapy in Hypoxemic Chronic Obstructive Lung DiseaseAnnals of Internal Medicine, 1980